Device and pharmaceutical manufacturers must understand the differences in scientific expectations and cultural environments between CDRH and CDER to obtain FDA approval of drug-device combination ...

A new UCLA-led study has identified multiple new risk genes for Alzheimer's disease and a rare, related brain disorder called progressive supranuclear palsy (PSP) by using a combination of new testing ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. There's PBC, there's PSC, and then there's ...

May 13 (Reuters) - Merck (MRK.N), opens new tab said on Monday it had discontinued an experimental combination treatment testing a new type of immunotherapy in patients with a severe form of skin ...

A new study has identified a combination of three existing drugs that significantly extends survival in mouse models of the lethal brain cancer glioblastoma multiforme (GBM). A Ludwig Cancer Research ...

The last time I wrote about Tango Therapeutics (TNGX) it was with a Seeking Alpha article entitled "Tango Therapeutics: PRMT5 inhibitor, vopimetostat, Approaches Pivotal Testing - Buy." With respect ...

In conjunction with the business combination agreement, the parties have several local and international commitments for new investments by institutional investors, including Digital Assets and ...

June 8 (Reuters) - Tango Therapeutics said on Monday an experimental drug combination showed strong early results in a small study of patients with advanced pancreatic cancer and that it plans to ...

“That’s why we identified accelerated testing protocols that can be conducted in the laboratory to reveal how these cells would function after six months in operation outside.” Zhu is lead author of a ...

SEPTEMBER 20, 2022, NEW YORK – A Ludwig Cancer Research study has identified a combination of three existing drugs that significantly extends survival in mouse models of the lethal brain cancer ...